Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.

Nkontchou G, Ziol M, Aout M, Lhabadie M, Baazia Y, Mahmoudi A, Roulot D, Ganne-Carrie N, Grando-Lemaire V, Trinchet JC, Gordien E, Vicaut E, Baghad I, Beaugrand M.

J Viral Hepat. 2011 Oct;18(10):e516-22. doi: 10.1111/j.1365-2893.2011.01441.x.

PMID:
21914071
2.
3.

Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.

Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, Hamid S, Jafri W, Mizokami M.

J Med Virol. 2009 Jul;81(7):1189-97. doi: 10.1002/jmv.21466.

PMID:
19475617
4.

Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.

N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, Trinchet JC, Beaugrand M.

Clin Gastroenterol Hepatol. 2006 Aug;4(8):1062-8. Epub 2006 Jul 14.

PMID:
16844421
5.

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.

Cancer. 1999 May 15;85(10):2132-7.

PMID:
10326690
6.

A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis.

Tanaka K, Sakai H, Hashizume M, Hirohata T.

Jpn J Cancer Res. 1998 Dec;89(12):1241-50.

PMID:
10081484
7.

Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.

Adinolfi LE, Utili R, Andreana A, Tripodi MF, Rosario P, Mormone G, Ragone E, Pasquale G, Ruggiero G.

Eur J Gastroenterol Hepatol. 2000 Mar;12(3):299-304.

PMID:
10750650
8.

Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.

Larsen C, Bousquet V, Delarocque-Astagneau E, Pioche C, Roudot-Thoraval F; HCV Surveillance Steering Committee; HCV Surveillance Group, Desenclos JC.

J Med Virol. 2010 Oct;82(10):1647-54. doi: 10.1002/jmv.21850.

PMID:
20827760
9.

Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.

Tarao K, Fujiyama S, Ohkawa S, Miyakawa K, Tamai S, Hirokawa S, Masaki T, Tanaka K.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):164-9.

10.

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A.

Cancer. 1994 Nov 1;74(9):2442-8.

11.

PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.

Guyot E, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Beaugrand M, Charnaux N, Trinchet JC, Nahon P.

J Hepatol. 2013 Feb;58(2):312-8. doi: 10.1016/j.jhep.2012.09.036. Epub 2012 Oct 13.

PMID:
23069476
12.

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

Silini E, Bottelli R, Asti M, Bruno S, Candusso ME, Brambilla S, Bono F, Iamoni G, Tinelli C, Mondelli MU, Ideo G.

Gastroenterology. 1996 Jul;111(1):199-205.

PMID:
8698200
13.

High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.

Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H.

J Med Virol. 2002 Aug;67(4):501-9.

PMID:
12115995
14.
15.

Hepatitis C virus genotypes and the development of hepatocellular carcinoma.

Stankovic-Djordjevic D, Djordjevic N, Tasic G, Dinic M, Karanikolic A, Pesic M.

J Dig Dis. 2007 Feb;8(1):42-7.

PMID:
17261134
16.
17.

[An analysis of clinical characteristics and risk factors of cirrhosis-related hepatocellular carcinomas in patients with hepatitis C virus infection].

Wu CH, Tian GS, Xu XY, Yu YY, Huang T.

Zhonghua Gan Zang Bing Za Zhi. 2008 Mar;16(3):210-4. Chinese.

PMID:
18364082
18.

Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.

Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1439-46. doi: 10.1158/1055-9965.EPI-11-0341. Epub 2011 May 24.

19.

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN.

Hepatology. 2010 Jun;51(6):1972-8. doi: 10.1002/hep.23527.

PMID:
20209604
20.

Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt.

Ryu SH, Fan X, Xu Y, Elbaz T, Zekri AR, Abdelaziz AO, Di Bisceglie AM.

J Med Virol. 2009 May;81(5):844-7. doi: 10.1002/jmv.21451.

PMID:
19319951

Supplemental Content

Support Center